. 2020 Sep;9(9):5117–5127. doi: 10.21037/tcr-19-2397

Table 1. Clinical characteristics in all the patients.

Variables	PNI-NLR group				PNI			NLR
Variables	Group 1	Group 2	Group 3	P	PNI-high	PNI-low	P	NLR-high	NLR-low	P
Age (year)	60.20±8.49	61.57±8.92	63.19±9.05	0.15	59.97±8.85	61.76±8.57	0.13	61.49±9.58	61.25±8.48	0.84
Sex
Female	24	19	7	0.31	21	29	0.18	11	39	0.16
Male	80	102	39	0.31	119	102	0.18	71	150	0.16
TNM stage
I–II	57	68	16	0.04	76	65	0.52	35	106	0.06
III–IVA	47	53	30	0.04	64	66	0.52	47	83	0.06
N stage
N−	57	69	21	0.42	77	70	0.89	41	106	0.43
N+	47	52	25	0.42	63	61	0.89	41	83	0.43
Smoking
Yes	75	79	36	0.22	101	89	0.53	62	128	0.25
No	29	42	10	0.22	39	42	0.53	20	61	0.25
Drinking
Yes	76	79	37	0.12	102	90	0.54	63	129	0.19
No	28	42	9	0.12	38	41	0.54	19	60	0.19
Tumor length
≤5 cm	60	70	22	0.47	80	72	0.72	42	110	0.29
˃5 cm	44	51	24	0.47	60	59	0.72	40	79	0.29
Tumor location
Upper	11	10	3	0.79	15	9	0.37	7	17	0.99
Middle	39	48	15		55	47	0.37	31	71
Lower	54	63	28		70	75		44	101
Differentiation
Well	12	14	3	0.25	14	15	0.71	5	24	0.27
Middle	60	78	24		87	75		51	111
Poor	32	29	19		39	41		26	54

NLR, neutrophil to lymphocyte ratio; PNI, prognostic nutritional index.